SCHEMBL13348992

SCHEMBL13348992

CC(CCCCCCCC(=O)N=O)C(=O)c1ccccc1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.36
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 6/20 0.36
HPGD P15428 5/20 0.36
LMNA P02545 4/20 0.35
HDAC1 Q13547 1/20 0.35
HTT P42858 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
HSD17B10 Q99714 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 2/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
HMGB1 P09429 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28192977 0.81 NAAA (0.54) NAAAALDH1A1LMNAHTTTSHR
SCHEMBL9717253 0.81 NAAA (0.54) NAAAALDH1A1LMNAHTTTSHR
SCHEMBL22955842 0.75 LMNA (0.46) NAAAALDH1A1KDM4EHPGDLMNA
SCHEMBL13990331 0.71 ALDH1A1 (0.54) NAAAALDH1A1LMNAHTTTDP1
SCHEMBL10535966 0.71 KDM4E (0.49) NAAAALDH1A1KDM4EHPGDLMNA
SCHEMBL9054290 0.70 CYP19A1 (0.46) ALDH1A1LMNAHDAC1HTTTDP1
SCHEMBL10965657 0.69 CYP19A1 (0.49) ALDH1A1KDM4EHPGDLMNAHTT
SCHEMBL11581394 0.68 KDM4E (0.48) ALDH1A1KDM4EHPGDLMNAHTT
SCHEMBL7606068 0.68 NAAA (0.38) NAAAALDH1A1KDM4EHPGDLMNA
SCHEMBL30992859 0.68 L3MBTL1 (0.47) NAAAALDH1A1SMN1; SMN2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160556-A1 GLP-1 Fusion Peptides Conjugated to Polymer(s), Their Production and Use BIOCOMPATIBLES UK LTD. (GB) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160556-A1 GLP-1 Fusion Peptides Conjugated to Polymer(s), Their Production and Use IAPP, GIPR, GLP1R NAAA 3552/4885ALDH1A1 4113/4885KDM4E 3541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.